Clinical Trial Update: A Study of VV-14305 for the Treatment of Thyroid Eye Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update for VV-14305 in Thyroid Eye Disease, sponsored by Kriya Therapeutics; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Eye Disease

Drugs mentioned

• VV-14305

Snippet

Sponsor: Kriya Therapeutics, Inc. | Conditions: Thyroid Eye Disease (TED) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING